Atlas Trials

Phase 1

65,473 clinical trials · Phase

Sort:Newest firstOldest first

◉ Watch Phase 1

RecordFirmDate
Investigation of Safety, Tolerability and Maximum Tolerated Dose (MTD) of BI 2536 in Patients With Recurrent Advanced Aggressive Non-Hodgkin's Lymphoma (NHL) (NCT00243087)Boehringer Ingelheim2005-07-01
Chlorproguanil-Dapsone in Pregnant Women (NCT00126971)Centers for Disease Control and Prevention2005-07-01
Fasting Study of Ondansetron Orally Disintegrating Tablets 8 mg to Zofran ODT® Tablets 8 mg (NCT00649363)Mylan Pharmaceuticals Inc2005-07-01
Oxcarbazepine 600 mg Tablets Under Non-Fasting Conditions (NCT00849797)Teva Pharmaceuticals USA2005-07-01
Folate and Protection Against Cervical Cancer (NCT00220532)Sheffield Teaching Hospitals NHS Foundation Trust2005-07-01
SB-659032 Platelet Aggregation Study (NCT01745458)GlaxoSmithKline2005-07-01
A Phase I Trial of ZIO-101 in Solid Tumors (NCT00591396)Alaunos Therapeutics2005-07-01
Bioequivalence Study of Sumatriptan Succinate Tablets 100 mg in Fed Conditions (NCT01269281)Dr. Reddy's Laboratories Limited2005-07-01
Safety and Efficacy Trial of Imexon Plus DTIC in Advanced Malignant Melanoma (NCT00327600)AmpliMed Corporation2005-07-01
An Open-Label Trial of Donepezil in Fragile X Syndrome (NCT00220584)Stanford University2005-07-01
VNP40101M in Treating Patients With Richter Syndrome or Refractory or Relapsed Chronic Lymphocytic Leukemia or Other Lymphoproliferative Disorders (NCT00304005)Vion Pharmaceuticals2005-07-01
A Dietary Intervention- Randomized Controlled Trial (DIRECT) Study; BGU-Harvard-Robarts Collaboration (NCT00160108)The S. Daniel Abraham International Center for Health and Nutrition2005-07-01
A Study to Evaluate PT-523 in Patients With Refractory Leukemia (NCT00129558)Spectrum Pharmaceuticals, Inc2005-07-01
Cefdinir Capsules 300 mg, Non-fasting (NCT00834535)Teva Pharmaceuticals USA2005-07-01
Treatment for Acute Spinal Cord Injury (NCT00695149)Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan2005-07-01
Pharmacokinetic Interactions Between Antiretroviral Agents and Antimalarial Drug Combinations (NCT00697892)Fran Aweeka2005-07-01
A Study to Test the Tolerability of an Investigational Electroporation Device in Healthy Adults (V930-001) (NCT00721461)Merck Sharp & Dohme LLC2005-07-01
Effect of Epidural Anesthesia on Pancreatic Perfusion and Clinical Outcome in Patients With Severe Acute Pancreatitis (NCT01607996)University Hospital, Geneva2005-07-01
Effect of Tamsulosin vs Prazosin in Treatment of Female Voiding Dysfunction (NCT00602186)Tabriz University2005-07-01
"PTHrP(1-36) IV Dose Escalation Study" (NCT00177411)University of Pittsburgh2005-07-01
Reduced Intensity Transplant Using Extracorporeal Photopheresis (NCT00179790)Ann & Robert H Lurie Children's Hospital of Chicago2005-07-01
3-Week Parathyroid Hormone-related Protein (PTHrP) Dose Escalation Study in Post-Menopausal Women (NCT00222872)University of Pittsburgh2005-07-01
Safety and Efficacy of Bone Marrow Cell Transplantation in Humans Myocardial Infarction (NCT00437710)Azienda Unita Sanitaria Locale di Piacenza2005-07-01
H5N1 Vaccine Intramuscular Versus Intradermal in Healthy Adults (NCT00310206)National Institute of Allergy and Infectious Diseases (NIAID)2005-07-01
A Study of MK-0893 on Glucagon-Induced Glycemic Excursion in Healthy Male Participants Following Intravenous Administration of Glucagon, Sandostatine® and Insulin (MK-0893-002) (NCT02012166)Merck Sharp & Dohme LLC2005-07-01
Cefdinir Capsules 300 mg, Fasting (NCT00835484)Teva Pharmaceuticals USA2005-07-01
Safety and Immunogenicity Study of Plasmodium Vivax CS Derived Synthetic Peptides Formulated in Two Adjuvants (NCT01081847)Malaria Vaccine and Drug Development Center2005-07-01
Pentostatin, Cyclophosphamide, Rituximab, and Mitoxantrone in Treating Patients With Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Cancer (NCT00546377)Memorial Sloan Kettering Cancer Center2005-07-01
Fasting Study of Doxycycline Monohydrate Tablets 100 mg and Adoxa Tablets 100 mg (NCT00649571)Mylan Pharmaceuticals Inc2005-07-01
Relapse Prevention for Suicidal Dually Diagnosed Youths (NCT00589641)Duke University2005-07-01
A First In Human Study Of PF-00184562 In Healthy Volunteers (NCT00150215)Pfizer2005-07-01
SPECT Investigation Of The NMDA Receptor System In Healthy Volunteers And Patients With Schizophrenia (NCT00364429)GlaxoSmithKline2005-07-01
Safety, Tolerability, and Immunogenicity Study of a Clostridium Difficile Toxoid Vaccine in Healthy Adult Volunteers (NCT00127803)Sanofi2005-07-01
Lenalidomide and GM-CSF in Treating Patients With Prostate Cancer (NCT00939510)Robert Dreicer MD2005-07-01
GVAX in Advanced Prostate Cancer Patients Made Lymphopenic (NCT00122005)Providence Health & Services2005-07-01
A Study of Paliperidone Blood Concentrations in Patients With Schizophrenia After Administration of Paliperidone Palmitate (NCT01110317)Johnson & Johnson Pharmaceutical Research & Development, L.L.C.2005-07-01
Comparison of Dendritic Cells Versus Montanide as Adjuvants in a Melanoma Vaccine (NCT00124124)Dr. Nina Bhardwaj2005-07-01
Safety and Immunogenicity of CHP-HER2 and CHP-NY-ESO-1 Protein With OK-432 in Antigen-Expressing Cancers (NCT00291473)Ludwig Institute for Cancer Research2005-07-01
Targeted Atomic Nano-Generators (Actinium-225-Labeled Humanized Anti-CD33 Monoclonal Antibody HuM195) in Patients With Advanced Myeloid Malignancies (NCT00672165)Memorial Sloan Kettering Cancer Center2005-07-01
An Open-Label Study of E7974 Administered on Days 1, 8, and 15 of a 28-Day Cycle and Days 1 and 8 of a 21-Day Cycle in Patients With Solid Malignancies (NCT00121732)Eisai Inc.2005-07-01
Evaluation of Safety of Rexin-G Gene Transfer for Advanced Pancreatic Cancer (NCT00121745)Epeius Biotechnologies2005-07-01
A Relative Bioavailability Study of 60 mg Nifedipine Extended Release Tablets Under Fasting Conditions (NCT00865891)Actavis Inc.2005-07-01
Safety of and Immune Response to a Tick-Borne Encephalitis Vaccine (LGT(TP21)/DEN4) in Healthy Adults (NCT00118924)National Institute of Allergy and Infectious Diseases (NIAID)2005-07-01
Bortezomib in Treating Patients With Multiple Myeloma Who Have Undergone an Autologous Peripheral Blood Stem Cell Transplant (NCT00288028)Barbara Ann Karmanos Cancer Institute2005-07-01
Granisetron 1 mg Tablets, Non-fasting (NCT00834522)Teva Pharmaceuticals USA2005-07-01
Vorinostat and Bortezomib in Treating Patients With Metastatic or Unresectable Solid Tumors (NCT00227513)National Cancer Institute (NCI)2005-07-01
Topical Agent for Treatment of Red Skin (NCT00279890)Mayo Clinic2005-07-01
Bioequivalence Study Between Two Oral Formulations of Gemfibrozil Tablets (NCT00800475)Blu Caribe2005-07-01
Resveratrol for Patients With Colon Cancer (NCT00256334)University of California, Irvine2005-07-01
Combination 5-azacitidine and Gemtuzumab Ozogamicin Therapy for Treatment of Relapsed Acute Myeloid Leukemia (AML) (NCT00766116)University of California, San Diego2005-07-01
Safety, Tolerability and Immunogenicity of the Venezuelan Equine Encephalitis (VEE) Attenuated Live-Virus Vaccine (NCT00109304)DynPort Vaccine Company LLC, A GDIT Company2005-07-01
Food Study of Ondansetron Orally Disintegrating Tablets 8 mg to Zofran ODT® Tablets 8 mg (NCT00648804)Mylan Pharmaceuticals Inc2005-07-01
Safety and Dose Study of GRN163L to Treat Patients With Chronic Lymphoproliferative Disease(CLD) (NCT00124189)Geron Corporation2005-07-01
Reliability of Dosing With NovoLog® Mix 70/30 FlexPen® Compared With Vial and Syringe (NCT00127296)Novo Nordisk A/S2005-07-01
Immunotherapy for Colorectal Cancers Using CEA-Pulsed Dendritic Cells and Subsequent IL-2 Treatment (NCT00154713)National Taiwan University Hospital2005-07-01
Effects of Sage on Memory and Mental Performance in Alzheimer's Disease Patients (NCT00110552)Oregon Health and Science University2005-07-01
Safety Study of OXi4503 (a Vascular Disrupting Agent) Given by 3 x Weekly Intravenous Infusions to Patients With Advanced Solid Tumors (NCT00977210)Mateon Therapeutics2005-07-01
Safety and Feasibility Study of Dapivirine (TMC120) Vaginal Ring in Belgium (NCT00332995)International Partnership for Microbicides, Inc.2005-07-01
Deep Brain Stimulation for Treatment-Refractory Major Depression (NCT00122031)University Hospital, Bonn2005-07-01
A Safety Study in Patients With Chronic Lymphocytic Leukemia (NCT00283101)Seagen Inc.2005-07-01
Study of GC1008 in Patients With Idiopathic Pulmonary Fibrosis (IPF) (NCT00125385)Genzyme, a Sanofi Company2005-07-01
Pilot Studies of Novel Therapies to Treat Resistant Focal Segmental Glomerulosclerosis (FSGS) (NCT00193648)Northwell Health2005-07-01
Safety, Tolerability and Immune Response of IMVAMUNE (MVA-BN)Smallpox Vaccine in HIV Infected Patients (NCT00189904)Bavarian Nordic2005-07-01
Imatinib Mesylate, Vatalanib, and Hydroxyurea in Treating Patients With Recurrent or Relapsed Malignant Glioma (NCT00387933)Duke University2005-07-01
Pharmacokinetics of Mycophenolate Mofetil in Healthy Volunteers (NCT00128947)National Institutes of Health Clinical Center (CC)2005-07-01
Food Study of Doxycycline Monohydrate Tablets 100 mg and Adoxa Tablets 100 mg (NCT00648180)Mylan Pharmaceuticals Inc2005-07-01
Safety of and Immune Response to a Modified Vaccinia Ankara (MVA) HIV Vaccine in HIV Uninfected Adults (NCT00376090)U.S. Army Medical Research and Development Command2005-07-01
Yttrium Y 90 Anti-CD45 Monoclonal Antibody AHN-12 in Treating Patients With Advanced Leukemia (NCT00618696)Masonic Cancer Center, University of Minnesota2005-07-01
Use of Nanoparticle Paclitaxel (ABI-007) for the Prevention of In-Stent Restenosis (NCT00124943)Celgene Corporation2005-07-01
Vaccination of Patients With Stage IV Melanoma With Dendritic Cells (NCT00125749)Baylor Research Institute2005-07-01
Myopia Control by Combining Auricular Acupoint and Atropine Eyedrops (NCT00457717)China Medical University, China2005-07-01
A Phase I/Ib, Multicenter, Open-Label, Dose Escalation Study of E7080 in Patients With Solid Tumors and in Combination With Temozolomide in Patients With Advanced and/or Metastatic Melanoma (NCT00121680)Eisai Inc.2005-07-01
A Study of Xeloda (Capecitabine) in Combination With Oxaliplatin in Patients With Metastatic Colorectal Cancer. (NCT00353262)Hoffmann-La Roche2005-07-01
A Multicentre Phase I-II Study to Investigate the Combination of Bendamustine With Weekly Paclitaxel as First or Second Line Therapy in Patients With Metastatic Breast Cancer (NCT00661739)GBG Forschungs GmbH2005-07-01
Intranasal Recombinant Flagellin Subunit Campylobacter Vaccine (rFla-MBP) Dose-Ranging Study (NCT00124865)U.S. Army Medical Research and Development Command2005-07-01
Twice Daily Prevacid for the Treatment of Laryngopharyngeal Reflux (NCT00864396)University of California, Davis2005-07-01
The Effect of Good Bacteria on Nonalcoholic Fatty Liver Disease in Diabetics (NCT00068094)National Center for Complementary and Integrative Health (NCCIH)2005-07-01
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Dabigatran Etexilate in Patients With Moderate Hepatic Impairment Compared to Subjects With Normal Hepatic Function (NCT02170571)Boehringer Ingelheim2005-07-01
To Demonstrate the Relative Bioavailability of Sandoz Inc. and Tyco Healthcare (Tofranil) 50 mg Imipramine Hydrochloride Tablets In Healthy Adults Volunteers Under Fasting Conditions (NCT00946764)Sandoz2005-07-01
Imaging Colo-rectal Cancer Using a Two Step Antibody Technique in Nuclear Imaging (NCT00185081)Radboud University Medical Center2005-07-01
Effect of Benadryl Sedation During ERCP or EUS (NCT00240123)University of Rochester2005-07-01
Trial of Pemetrexed and Carboplatin in Patients With Recurrent Ovarian or Primary Peritoneal Cancer (NCT00489359)Eli Lilly and Company2005-07-01
Vorinostat, Paclitaxel, and Carboplatin in Treating Patients With Advanced or Refractory Solid Tumors (NCT00287937)National Cancer Institute (NCI)2005-07-01
Suberoylanilide Hydroxamic Acid, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Progressive Metastatic or Unresectable Colorectal Cancer or Other Solid Tumors (NCT00138177)National Cancer Institute (NCI)2005-07-01
A Study of Palifermin for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer Receiving Postoperative Radiotherapy and Concurrent Chemotherapy (NCT00626639)Swedish Orphan Biovitrum2005-07-01
Processing and Effects of Cannabis (NCT00225407)UMC Utrecht2005-07-01
Antihypertensive Treatment in Acute Cerebral Hemorrhage (NCT00415610)University of Minnesota2005-07-01
Azacitidine and Recombinant Interferon Alfa-2b in Treating Patients With Stage III or Stage IV Melanoma or Stage IV Kidney Cancer That Cannot Be Removed By Surgery (NCT00217542)National Cancer Institute (NCI)2005-07-01
Study Evaluating Gefitinib (IRESSA®) in Subjects With Solid Malignancies That Are Locally Advanced, Recurrent or Metastatic (NCT00127829)AstraZeneca2005-07-01
Study of BMS-354825 in Subjects With CML Who Are Resistant to or Intolerant of Imatinib or Ph+All in Japan (NCT00337454)Bristol-Myers Squibb2005-07-01
ch14.18/CHO Bridging Study (NCT01704872)St. Anna Kinderkrebsforschung2005-07-01
Dose-escalation Study of CX-3543 in Patients With Advanced Solid Tumors or Lymphomas (NCT00955786)Cylene Pharmaceuticals2005-07-01
To Demonstrate the Relative Bioavailability of Cetirizine Hydrochloride/Pseudoephedrine Hydrochloride 5 mg/120 mg Extended Release (ER) Tablets Under Fasting Conditions (NCT00881127)Sandoz2005-07-01
Efficacy Study of Weekly Topotecan With Cisplatin in Advanced Stage or Recurrent Cervical Cancer (NCT00322920)University of Alabama at Birmingham2005-07-01
Randomized Evaluation of Intracoronary Transplantation of Bone Marrow Stem Cells in Myocardial Infarction (NCT00874354)Cedars-Sinai Medical Center2005-07-01
CPAP Therapy in Patients With Heart Failure and Obstructive Sleep Apnea. (NCT00756366)Ottawa Heart Institute Research Corporation2005-07-01
Combination Herbal Therapy (CHT) Versus Placebo in Patients With Irritable Bowel Syndrome (IBS) (NCT00130741)Hadassah Medical Organization2005-07-01
Study of Samarium Sm-153 Lexidronam Combined With Docetaxel for Patients With Prostate Cancer (NCT00121095)Cytogen Corporation2005-07-01
Fish Oil for the Treatment of Depression in Patients With Multiple Sclerosis (NCT00122954)Oregon Health and Science University2005-07-01
ZD6474(Vandetanib) + Alimta Combo Study (NCT00506051)Genzyme, a Sanofi Company2005-07-01
← Previous Next →

Track Phase 1 automatically

Every clearance here is in the API, with alerts when new ones post.